{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:15:11Z","timestamp":1769847311929,"version":"3.49.0"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"abstract":"<jats:title>Development and validation of a bioanalytical LC-UV method with solid-phase extraction for determination of valproic acid in saliva<\/jats:title><jats:p>A bioanalytical HPLC method with UV detection for the determination of the antiepileptic drug valproic acid in human saliva has been developed and validated. Saliva represents an alternative matrix for therapeutic monitoring of antiepileptic drugs due to the increasing interest in free drug concentration. The proposed method involved solid-phase extraction for sample preparation and yielded very good mean recoveries of 99.4 % and 97.9 % for valproic acid and IS, respectively. The calibration function for valproic acid was linear over the concentration range of 1.0-50.0 \u03bcg mL<jats:sup>-1<\/jats:sup>(<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>= 0.9989). Within-run and between-run precision and accuracy were studied at four concentrations and RSDs were less than 7.3 and 2.2 %, while accuracy values were higher than 96.8 and 97.5 %, respectively. The described method provides sensitivity, linearity, precision, accuracy and is suitable for analyses of valproic acid in saliva samples.<\/jats:p>","DOI":"10.2478\/v10007-012-0015-0","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T14:49:11Z","timestamp":1340981351000},"page":"211-220","source":"Crossref","is-referenced-by-count":20,"title":["Development and validation of a bioanalytical LC-UV method with solid-phase extraction for determination of valproic acid in saliva"],"prefix":"10.2478","volume":"62","author":[{"given":"Jasmina","family":"Tonic-Ribarska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlinda","family":"Haxhiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Sterjev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Kiteva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ljubica","family":"Suturkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Trajkovic-Jolevska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1528-1157.1984.tb05641.x","article-title":"Rational use of valproate: Indications and drug regimen in epilepsy","volume":"25","author":"P. Loiseau","year":"1984","journal-title":"Epilepsy"},{"key":"2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0387-7604(86)80119-X","article-title":"Sodium valproate monotherapy in childhood epilepsy","volume":"8","author":"O. Dulac","year":"1986","journal-title":"Brain Dev"},{"key":"3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cnr.2004.09.013","article-title":"Valproic acid: How it works. Or not","volume":"4","author":"D. Lagacea","year":"2004","journal-title":"Clin. Neurosci. Res"},{"key":"4","first-page":"333","article-title":"Bioanalytical method development - Determination of drugs in biological fluids","volume":"2","author":"P. Wal","year":"2010","journal-title":"J. Pharm. Sci. Tech"},{"key":"5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1567-7192(04)80010-X","article-title":"Therapeutic Drug Monitoring of Antiepileptic Drugs","volume":"5","author":"S. Johannessen","journal-title":"Handbook of Analytical Separation"},{"key":"6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on the therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","author":"P. Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.5858\/1999-123-0822-FDM","article-title":"Free drug measurement","volume":"123","author":"S. Soldin","year":"1999","journal-title":"Arch. Pathol. Lab. Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/00003088-199936060-00006","article-title":"Therapeutic drug concentration monitoring using saliva samples","volume":"36","author":"H. Liu","year":"1999","journal-title":"Clin. Pharmacokin"},{"key":"9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3343\/kjlm.2007.27.5.330","article-title":"Evaluation of Viva-E drug testing system","volume":"27","author":"H. Chung","year":"2007","journal-title":"Korean J. Lab. Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-4347(96)00405-7","article-title":"Methods to reduce background interferences in electron-capture gas chromathographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromide","volume":"690","author":"R. Dills","year":"1997","journal-title":"J. Chromatogr. B Biomed. Appl"},{"key":"11","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1081\/JLC-120014953","article-title":"Determination of valproic acid in human plasma by HPLC with fluorescence detection","volume":"25","author":"S. Rompotis","year":"2002","journal-title":"J. Liq. Chromatogr"},{"key":"12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jchromb.2005.11.028","article-title":"Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization","volume":"830","author":"H. Amini","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.talanta.2006.09.033","article-title":"A high through and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS\/MS","volume":"72","author":"D. Jain","year":"2007","journal-title":"Talanta"},{"key":"14","unstructured":"<i>Guideline on validation of bioanalytical methods<\/i>, European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), London 2009; <a target=\"_blank\" href='http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/12\/WC500018062.pdf'>http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/12\/WC500018062.pdf<\/a>"},{"key":"15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/03784347(95)00273-8","article-title":"Solid-phase microextraction for the determination of the free concentration of valproic acid in human plasma by capillary gas chromatography","volume":"673","author":"M. Krogh","year":"1995","journal-title":"J. Chromatogr. B"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/acph\/62\/2\/article-p211.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/view\/j\/acph.2012.62.issue-2\/v10007-012-0015-0\/v10007-012-0015-0.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T22:29:48Z","timestamp":1642631388000},"score":1,"resource":{"primary":{"URL":"https:\/\/content.sciendo.com\/doi\/10.2478\/v10007-012-0015-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":15,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2478\/v10007-012-0015-0","relation":{},"ISSN":["1846-9558","1330-0075"],"issn-type":[{"value":"1846-9558","type":"electronic"},{"value":"1330-0075","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,1]]}}}